526 related articles for article (PubMed ID: 32494148)
1. Vascular Calcification: An Important Understanding in Nephrology.
Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
Filipska I; Winiarska A; Knysak M; Stompór T
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
[TBL] [Abstract][Full Text] [Related]
3. Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.
Chao CT; Lin SH
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371477
[TBL] [Abstract][Full Text] [Related]
4. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
[TBL] [Abstract][Full Text] [Related]
5. Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology.
Yaker L; Kamel S; Ausseil J; Boullier A
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371311
[TBL] [Abstract][Full Text] [Related]
6. Phosphate is a vascular toxin.
Shroff R
Pediatr Nephrol; 2013 Apr; 28(4):583-93. PubMed ID: 23161206
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
8. Vascular toxicity of phosphate in chronic kidney disease: beyond vascular calcification .
Gross P; Six I; Kamel S; Massy ZA
Circ J; 2014; 78(10):2339-46. PubMed ID: 25077548
[TBL] [Abstract][Full Text] [Related]
9. Role of Uremic Toxins in Early Vascular Ageing and Calcification.
Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534
[TBL] [Abstract][Full Text] [Related]
10. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
Rapp N; Evenepoel P; Stenvinkel P; Schurgers L
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
[TBL] [Abstract][Full Text] [Related]
12. Vascular calcification in CKD: New insights into its mechanisms.
Ding N; Lv Y; Su H; Wang Z; Kong X; Zhen J; Lv Z; Wang R
J Cell Physiol; 2023 Jun; 238(6):1160-1182. PubMed ID: 37269534
[TBL] [Abstract][Full Text] [Related]
13. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
14. Magnesium as a Calcification Inhibitor.
Hénaut L; Massy ZA
Adv Chronic Kidney Dis; 2018 May; 25(3):281-290. PubMed ID: 29793668
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future therapy.
Pongsuwan K; Kusirisin P; Narongkiattikhun P; Chattipakorn SC; Chattipakorn N
J Cell Physiol; 2022 Dec; 237(12):4369-4396. PubMed ID: 36183389
[TBL] [Abstract][Full Text] [Related]
16. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.
Ruderman I; Hewitson TD; Smith ER; Holt SG; Wigg B; Toussaint ND
BMC Nephrol; 2020 Jul; 21(1):279. PubMed ID: 32677907
[TBL] [Abstract][Full Text] [Related]
17. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
[TBL] [Abstract][Full Text] [Related]
18. Pyrophosphate deficiency in vascular calcification.
Villa-Bellosta R; O'Neill WC
Kidney Int; 2018 Jun; 93(6):1293-1297. PubMed ID: 29580636
[TBL] [Abstract][Full Text] [Related]
19. Role of hyperphosphatemia-mediated vascular calcification in cardiovascular outcomes and its management: a review.
Latif F; Khalid MM; Khan F; Omar Z; Ali FA
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):410-5. PubMed ID: 23392553
[TBL] [Abstract][Full Text] [Related]
20. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Liabeuf S; Okazaki H; Desjardins L; Fliser D; Goldsmith D; Covic A; Wiecek A; Ortiz A; Martinez-Castelao A; Lindholm B; Suleymanlar G; Mallamaci F; Zoccali C; London G; Massy ZA
Nephrol Dial Transplant; 2014 Jul; 29(7):1275-84. PubMed ID: 24009287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]